CN Stock MarketDetailed Quotes
301277 Newland Pharmaceutical
- 13.65
- -0.25-1.80%
Market Closed Jun 20 15:00 CST
3.82BMarket Cap22.71P/E (TTM)
14.45High13.65Low99.58KlotVolume13.78Open13.90Pre Close140.14MTurnover14.21%Turnover Ratio24.03P/E (Static)280.06MShares22.2052wk High2.68P/B956.26MFloat Cap9.0152wk Low16.68Limit Up70.06MShs Float24.24Historical High11.12Limit Down5.76%Amplitude9.01Historical Low0.29Dividend TTM14.07Avg Price52.59KlotAsk2.10%Div YieldTTM100Lot Size43.78KlotBid
About Newland Pharmaceutical Company
The company was founded in 2005 with a registered capital of 99 million yuan and current assets of 570 million yuan. Mainly engaged in R&D, production and sales of pharmaceutical intermediates and fine chemicals. The company is mainly engaged in the production, development and sale of pharmaceutical intermediates, APIs and chemical preparations. The company's main products are L-p-hydroxyphenylglycine series products and p-toluene sulfonate products. The company received the honor of “Waste-free Factory” in Xuchang City.
Company Profile
Short Name-A新天地
Symbol-A301277
Company NameNewland Pharmaceutical Co., Ltd.
Listing DateNov 16, 2022
Issue Price27.00
Shares Offered33.36M share(s)
FoundedSep 15, 2005
Legal Representativejianzhong xie
General Managerluwei zhang
Secretaryyanzi wu
Accounting FirmGrant Tung Certified Public Accountants (Special General Partnership)
Securities Representativeyanzi wu
Legal CounselBeijing Tianyuan Law Firm
Employees937
Phone0374-6103777
Office AddressEast side of the southern section of Weiwu Road, Changge City
Zip Code461500
Registered AddressEast side of the southern section of Weiwu Road, Changge City, Xuchang City, Henan Province
Fax0374-6105968
Emailboard@hnnewland.com
Business License411082100006960
BusinessProduction, development and sale of pharmaceutical intermediates, APIs, and chemical pharmaceutical preparations (excluding hazardous chemicals, with the exception of products prohibited by the country); import and export of goods or technology (with the exception of goods and technology prohibited by the country or involving administrative examination and approval).
Company Executives
- Name
- Position
- Salary
- jianzhong xie
- Chairman，directors
- 567.30K
- wanmin liu
- Vice Chairman，directors
- 438.90K
- hongmin liu
- directors
- 600.00K
- chao liu
- directors，Deputy General Manager，Chief engineer
- 401.80K
- binggang zhang
- directors
- --
- luwei zhang
- directors，general manager
- 482.40K
- yu ke
- Independent directors
- 60.00K
- jingbao wang
- Independent directors
- 60.00K
- faliang jia
- Independent directors
- 60.00K
- yanzi wu
- Board Secretary，Securities affairs representative
- 156.20K
- heping xu
- Chairman of the Supervisory Board，auditors
- --
- zhangchun liu
- auditors
- --
- liying wang
- Deputy General Manager
- 303.90K
- qingkui wang
- Chief Financial Officer
- 379.70K
- weidong wu
- Employee supervisors
- 122.80K
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg